Benecchi Christopher - Insider Non-Derivative Transactions at Sage Therapeutics, Inc. (SAGE) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jul 31, 2025, Benecchi Christopher's relationship to Sage Therapeutics, Inc. (SAGE) is Officer (Chief Operating Officer), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SAGE insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Benecchi Christopher - Insider Non-Derivative Transactions of SAGE Common Stock

Benecchi Christopher - Insider Non-Derivative Transactions at SAGE

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Aug 1, 2025	Disposition -- (Common Stock)	28053	0	0
Aug 1, 2025	Disposition -- (Common Stock)	36375	0	0
Apr 11, 2025	F -- (Common Stock)	793	6.91	46377
Apr 11, 2025	Acquisition -- (Common Stock)	3255	0	47170
Apr 11, 2025	F -- (Common Stock)	661	6.91	48428
Apr 11, 2025	Acquisition -- (Common Stock)	2712	0	49089
Feb 14, 2025	F -- (Common Stock)	822	7.18	43915
Jan 17, 2025	Acquisition -- (Common Stock)	20000	0	44737
Nov 2, 2024	Acquisition -- (Common Stock)	6250	0	24737
Aug 6, 2024	F -- (Common Stock)	4755	8.96	18487
Aug 6, 2024	Acquisition -- (Common Stock)	16200	0	23242
Feb 14, 2024	Acquisition -- (Common Stock)	13500	0	19430
Feb 4, 2023	F -- (Common Stock)	2119	44.16	5260
Feb 4, 2023	Acquisition -- (Common Stock)	6750	0	7379